Top Clinical Trials companies in Singapore by EBITDA
This ranking features the top 1 Clinical Trials companies in Singapore ranked by EBITDA, totalling a EBITDA of USD -58.79 M, for January 15, 2025.
Singapore
Clinical Trials
EBITDA
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -58.79 M
|
Dec. 31, 2023 | USD 11.13 | -1.24% |
|
Singapore |
Frequently Asked Questions
-
Which Clinical Trials company in Singapore has the highest EBITDA ?
The Clinical Trials company in Singapore with the highest EBITDA is Wave Life Sciences Ltd. (NasdaqGM: WVE) at USD -58.79 M.
-
Which Clinical Trials company in Singapore has the lowest EBITDA ?
The Clinical Trials company in Singapore with the lowest EBITDA is Wave Life Sciences Ltd. (NasdaqGM: WVE) at USD -58.79 M.
-
What are the top 10 Clinical Trials companies in Singapore by EBITDA ?
The top 10 Clinical Trials companies in Singapore by EBITDA are and Wave Life Sciences Ltd..
-
What are the bottom 10 Clinical Trials companies in Singapore by EBITDA ?
The bottom 10 Clinical Trials companies in Singapore by EBITDA are and Wave Life Sciences Ltd..